BioSpace News Archive

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated multi-state cannabis operator in the United States, today announced a month-long, multi-state fundraising initiative in which proceeds will benefit ten locally-run organizations across the U.S. that cater to the unique needs of the women and families affected by breast cancer

Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Sarah Noonberg, M.D., Ph.D., has been appointed as the company’s chief medical officer. Dr. Noonberg brings significant industry and clinical experience to Maze as the company works to advance its pipeline. “Sarah is an exceptional leader who has helped guide multiple companies through various sta

General Atlantic, a leading global growth equity firm, today announced that Brett Zbar, MD, has joined the firm as a Managing Director and Global Head of Life Sciences.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711.

The pursuit of an effective therapeutic intervention for dementia has inspired interest in the class of medications known as tyrosine kinase inhibitors (TKIs)

The American Academy of Pediatrics (AAP), a 67,000-member organization dedicated to the optimal health and well-being for all infants, children, adolescents and young adults, and RQI Partners LLC announced today they will collaborate to create new educational programs for neonatal resuscitation in U.S. hospitals.

Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, is scheduled to participate in a virtual presentation and fireside chat at the October 2020 Lytham Partners Virtual Investor Conference on Wednesday, October 7, 2020 at 2:00pm ET.

Neurotrope, Inc. (Nasdaq: NTRP) today announced dosing of the first patient in its ongoing, long-term Phase 2 study of Bryostatin-1 for the treatment of Alzheimer’s disease (“AD”).

Karius, the world leader in liquid biopsy for infectious diseases, announced Alec Ford as the company’s new Chief Executive Officer (CEO).

Seasoned healthcare executive specializing in business acceleration brings strategic experience to telehealth company’s board of directors